Towards xenotransplantation: Genetically altered pig kidneys prove viable in non-human primates

Researchers used a genetically engineered porcine donor to develop kidney grafts.

Sionna and Odyssey end JPM week with IPO filings

Sionna Therapeutics and Odyssey Therapeutics have joined Metsera and Maze in an attempt to go public via the still rocky IPO route. The biotechs, focused

January 21, 2025

EC authorises ViiV Healthcare, J&J’s combo for adolescent HIV-1

The combo was approved by the EMA in December 2020 for use in virologically suppressed adults with HIV-1. Credit: ktsdesign/Shutterstock. The European Commission (EC) has

February 3, 2025

Discovery of TRPC5 gene’s role in obesity and postnatal depression offers hope for new treatments

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioral problems and, in mothers, postnatal depression. The discovery, reported today in Cell,

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.